Use Able AI chat for product recommendations

C1GALT1 Polyclonal antibody

C1GALT1 Polyclonal Antibody for WB, IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, IF/ICC, ELISA

B3Gal T8, Beta 1,3 galactosyltransferase, C1GALT, Core 1 beta3 Gal T1, Core 1 O glycan T synthase

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for C1GALT1 in ?

Tested Applications

Positive WB detected inMKN-45 cells, HepG2 cells, T-47D cells
Positive IF/ICC detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

27569-1-AP targets C1GALT1 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag26144

Product name: Recombinant human C1GALT1 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 263-363 aa of NM_020156

Sequence: MKETFHPFVPEHHLIKGYLPRTFWYWNYNYYPPVEGPGCCSDLAVSFHYVDSTTMYELEYLVYHLRPYGYLYRYQPTLPERILKEISQANKNEDTKVKLGNP

Predict reactive species
Full Name core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1
Calculated Molecular Weight 42 kDa
Observed Molecular Weight 42-45 kDa
GenBank Accession NumberNM_020156
Gene Symbol C1GALT1
Gene ID (NCBI) 56913
RRIDAB_2880912
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9NS00
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

C1GALT1 (Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1), also known as B3Gal-T8, catalyzes the transfer of galactose (Gal) from UDP-Gal to N-acetylgalactosamine (GalNAc) O-linked esters of threonine and serine residues of target proteins, including IgA1, to form the T antigen (PMID: 28209808). C1GalT1 is overexpressed in many common cancers includingcolon, breast, gastric, lung, head and neck, pancreatic, esophageal, prostate, and hepatocellular cancer (PMID: 34944925). C1GALT1 protein contains 363 amino acids and is a typeII transmembrane protein. Rate C1GalT1 is an 84/86KDa disulfide-bonded homodimer, but its active form is believed to be a 42/43 KDa monomeric protein (PMID: 34149900).

Protocols

Product Specific Protocols
IF protocol for C1GALT1 antibody 27569-1-APDownload protocol
WB protocol for C1GALT1 antibody 27569-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The C1GALT1 Polyclonal antibody (Cat# 27569-1-AP) has 3 total citations. These appear in International Immunopharmacology, Journal of Biomedical Research, and BMC Nephrology. The research fields covered include IgA nephropathy (specifically miR-98-5p-mediated IgA1 glycosylation regulation and dioscin's effect on Gd-IgA1 overproduction via IL-6/JAK2/STAT3 signaling) and gastric cancer (C1GALT1 genetic variants associated with cancer risk and immune infiltrations). Applications cited include WB and IHC in human samples.

SpeciesApplicationTitle
WB

Int Immunopharmacol

The upregulation of miR-98-5p affects the glycosylation of IgA1 through cytokines in IgA nephropathy.

Authors - Di Liu
humanIHC

J Biomed Res

Genetic variants in C1GALT1 are associated with gastric cancer risk and immune infiltrations

Authors - Mengfan Guo
humanWB

BMC Nephrol

Dioscin attenuates Gd-IgA1 overproduction by inhibiting the IL-6-JAK2/STAT3 signaling axis in IgA nephropathy.

Authors - Lan Lin
Loading...
||
New chat

Able™

正在加载,请稍候...